Skip to main content
. 2016 Jan 29;11:161–166. doi: 10.2147/COPD.S96809

Table 1.

Baseline characteristics at the initial visit

Total Emphysema (−) Emphysema (+) P-value
N 628 543 85
Age (years), median (Q1, Q3) 48 (40, 56) 48 (40, 56) 49 (42.5, 56) 0.16
Male sex 474 (75.5%) 403 (74.2%) 71 (83.5%) 0.08
Height (cm) 166.8±8.5 166.7±8.7 168.0±7.1 0.12
Body weight (kg) 67.1±10.9 66.8±10.9 69.0±10.3 0.10
BMI 24.0±3.0 24.0±2.9 24.4±3.3 0.21
Current smoker 271 (43.2%) 241 (44.4%) 30 (35.3%) 0.13
Noncurrent smoker
 Ex-smoker 150 (23.9%) 121 (22.3%) 29 (34.1%) 0.71
 Never smoker 207 (33.0%) 181 (33.3%) 26 (30.6%)
Pack years, median (Q1,Q3) 10.0 (0, 22.5) 10.0 (0, 22.5) 8.5 (0, 20) 0.87
FU duration (years) 3.1±1.4 3.1±1.4 3.2±1.4 0.87
PFT
 FVC (L) 4.02±0.84 4.00±0.84 4.18±0.82 0.06
 FVC (% predicted) 98.0±11.0 97.7±10.8 99.9±12.1 0.08
 FEV1 (L) 3.26±0.69 3.24±0.68 3.38±0.70 0.09
 FEV1 (% predicted) 105.7±12.4 105.3±12.5 107.9±12.2 0.08
 FEV1/FVC (%) 81.2±5.5 81.3±5.5 80.7±5.5 0.37
%LAA−950, median (Q1, Q3) 1.8 (0.6, 7.0) 1.3 (0.5, 4.3) 13.3 (11.2, 17.3) <0.001

Note: %LAA−950 is the percentage of low-attenuation area below −950 Hounsfield units measured by computed tomography quantification.

Abbreviations: N, Number; Q1, first quartile; Q3, third quartile; BMI, body mass index; FU, follow-up; PFT, pulmonary function test; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second.